Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation

British Journal of Haematology
Nicolaus KrögerTheo de Witte

Abstract

From 2002 to 2007, 49 myeloma patients who relapsed following autologous SCT were included in a prospective multicenter trial to determine the efficacy of a reduced melphalan/fludarabine regimen followed by allogeneic SCT from unrelated donors. All patients showed leucocyte and platelet engraftment after a median of 15 and 19 d, respectively. Grade II-IV acute graft-versus-host disease (GvHD) occurred in 25% of patients and 35% had chronic GvHD. Overall response rate at day 100 was 95% including 46% complete remission (CR). Cumulative incidence of non-relapse mortality at 1 year was 25% [95% confidence interval (CI): 13-37%] and was significantly lower for human leucocyte antigen (HLA)-matched compared to -mismatched SCT (10% vs. 53%, P = 0.001). The cumulative incidence of relapse at 3 years was 55% (95% CI: 40-70%). After a median follow up of 43 months, the estimated 5-year progression-free and overall survival rates were 20% and 26% respectively and were significantly better for matched in CR at day 100 (41% vs. 7%, P = 0.04 and 56% vs. 16%, P = 0.02). We conclude that optimal donor selection is mandatory for a low non-relapse mortality and high relapse incidence, which remains a major concern, should be improved by includi...Continue Reading

References

Aug 1, 1980·The American Journal of Medicine·H M ShulmanE D Thomas
Aug 3, 1996·Lancet·J AschanG Gahrton
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P CorradiniA Pileri
Jun 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G MartinelliM Cavo
Nov 25, 2000·British Journal of Haematology·J FinkeR Mertelsmann
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ashraf BadrosGuido Tricot
Apr 30, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Karl S PeggsKwee Yong
Nov 25, 2003·British Journal of Haematology·Bronwen E ShawUNKNOWN Clinical Trials Committee of the British Society of Blood and Marrow Transplantation
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kai SunWilliam J Murphy
Sep 25, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nicolaus KrögerAxel Rolf Zander
Feb 22, 2005·Bone Marrow Transplantation·K K BallenD H Vesole
May 27, 2005·British Journal of Haematology·Nicolaus KrögerUNKNOWN Clinical Trial Committee of the British Society of Blood and Marrow Transplantation and the German Cooperative Transplant Gr
Feb 9, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·George E GeorgesRainer Storb
Mar 3, 2007·European Journal of Haematology·Benedetto BrunoUNKNOWN Gruppo Italiano Trapianto Midollo Osseo
Jul 7, 2007·British Journal of Haematology·Martin KropffUNKNOWN Deutsche Studiengruppe Multiples Myelom,
Nov 23, 2007·The New England Journal of Medicine·Meletios DimopoulosUNKNOWN Multiple Myeloma (010) Study Investigators
Nov 23, 2007·The New England Journal of Medicine·Donna M WeberUNKNOWN Multiple Myeloma (009) Study Investigators
Feb 26, 2008·Bone Marrow Transplantation·H de LavalladeM Mohty
Mar 17, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nicolaus KrögerAxel Zander

❮ Previous
Next ❯

Citations

May 28, 2013·Bone Marrow Transplantation·H W AunerUNKNOWN Plasma Cell Dyscrasia Sub-committee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Tra
Sep 10, 2010·Current Opinion in Hematology·Nicolaus Kröger
Apr 14, 2015·Expert Opinion on Biological Therapy·Moreno FestucciaBenedetto Bruno
Jan 5, 2016·Bone Marrow Transplantation·B DhakalP N Hari
Jan 11, 2012·American Journal of Hematology·Qaiser BashirMuzaffar H Qazilbash
Jul 9, 2010·European Journal of Haematology·Gösta Gahrton
Mar 11, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Francesca PatriarcaRenato Fanin
Jul 23, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Qaiser BashirMuzaffar H Qazilbash
Dec 7, 2013·Clinical Lymphoma, Myeloma & Leukemia·Ivetta DanyleskoArnon Nagler
Jun 11, 2011·Clinical Lymphoma, Myeloma & Leukemia·Rachel B Salit, Michael R Bishop
Mar 30, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Roberto PasseraBenedetto Bruno
Oct 4, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Francesca PatriarcaPaolo Corradini
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henk LokhorstUNKNOWN International Myeloma Working Group
Jul 7, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bo BjörkstrandGösta Gahrton
May 17, 2018·Expert Review of Anticancer Therapy·Giusy CetaniStefania Oliva
Nov 15, 2013·Expert Review of Hematology·Gösta Gahrton, Amrita Krishnan
May 26, 2018·Bone Marrow Transplantation·Anna SuredaDavid L Porter
Jul 16, 2020·Journal of Clinical Medicine·Gösta GahrtonStefan Schönland
Oct 7, 2011·Cancer Control : Journal of the Moffitt Cancer Center·Taiga Nishihori, Melissa Alsina
Jan 13, 2018·Frontiers in Oncology·Ehsan MalekMarcos de Lima
Oct 30, 2020·Journal of Clinical Medicine·Alberto MussettiVittorio Montefusco
Sep 24, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Firoozeh SahebiParameswaran Hari
Jun 11, 2021·Current Treatment Options in Oncology·Panayotis Kaloyannidis, John Apostolidis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.